We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)—Should They Be Mandatory Supplements in Pregnancy?
Summary
This review covers the role of omega-3 fatty acids DHA and EPA during pregnancy and breastfeeding, finding they support fetal brain and eye development and may reduce the risk of preterm birth. While not directly about microplastics, it is relevant because seafood, the main source of these essential fats, is increasingly contaminated with microplastics. This creates a dilemma where the health benefits of eating fish must be weighed against potential microplastic exposure.
Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are essential fatty acids for the human body. Seafood and microalgae are the most important sources of omega-3 fatty acids. Supplementation with 200 mg/day of DHA during pregnancy and breastfeeding has been suggested for women and infants in countries with low seafood consumption. Maternal concentration of DHA and EPA was associated with concentration in cord blood and breast milk. High concentrations of DHA and EPA were identified at the level of retinal photoreceptors and neuronal cell membranes. It was observed that supplementation with DHA and EPA during pregnancy had beneficial effects on the neurological development of the fetus and infant by improving language, memory, attention, and hand coordination, affecting sleep patterns, and improving visual acuity. Beneficial effects on the development of the infant were also associated with the maternal intake of omega-3 fatty acids during breastfeeding. Supplementation with DHA and EPA may reduce the risk of preterm birth but also of preeclampsia in low-risk pregnancies. Women of childbearing age should have an intake of 250 mg/day of DHA + EPA from their diet or supplements. To reduce the risk of premature birth, pregnant women must additionally receive at least 100-200 mg of DHA every day. It is recommended that supplementation with omega-3 fatty acids starts before 20 weeks of pregnancy. Beneficial effects on the mother have been identified, such as the reduction of postpartum depression symptoms, the decrease of cardiovascular risk, and the anti-inflammatory role.
Sign in to start a discussion.
More Papers Like This
EPA and DHA in microalgae: Health benefits, biosynthesis, and metabolic engineering advances
This review examines how microalgae can be engineered to produce EPA and DHA, the beneficial omega-3 fatty acids traditionally sourced from fish oil. Microalgae offer a sustainable alternative because fish oil production is threatened by overfishing and climate change. While not directly about microplastics, this research matters because microplastic contamination of seafood is making algae-based omega-3 sources increasingly attractive for human nutrition.
Seafood Toxicant Exposure During Pregnancy, Lactation, and Childhood and Child Outcomes: A Scoping Review
Researchers conducted a scoping review of studies on toxicant exposure through seafood during pregnancy and childhood, finding that most research focuses on mercury while microplastics have received almost no study. This gap highlights the need for systematic research on how microplastic exposure through seafood affects fetal and child development.
Optimal omegas – barriers and novel methods to narrow omega-3 gaps. A narrative review
This review examines why most people worldwide do not consume enough omega-3 fatty acids, which are important for heart and brain health. Researchers identified barriers including limited access to oily fish, concerns about environmental contaminants like microplastics in seafood, and sustainability issues with fishing. The study highlights emerging alternatives such as algae-based supplements and bioengineered plant oils as promising ways to close the global omega-3 gap.
Impact of Microplastics on Pregnancy and Fetal Development: A Systematic Review
A systematic review of 12 studies confirmed the presence of microplastics ranging from 2.1 to 100 micrometers in human placentas and fetal tissue. Microplastic levels correlated with reduced birthweight, affected gestational age, diminished microbiome diversity, and impaired fetal growth and development, with lifestyle choices influencing placental microplastic burden.
Health Implications of Microplastic Exposure in Pregnancy and Early Childhood: A Systematic Review
This systematic review summarizes existing research on how microplastic exposure during pregnancy and early childhood may affect health. The evidence shows that microplastics can reach the placenta and may cause oxidative stress and inflammation, raising concerns about potential effects on fetal development and infant health during these vulnerable life stages.